The JI Acurri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, Y. C.
Right arrow Articles by Song, C. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, Y. C.
Right arrow Articles by Song, C. H.
The Journal of Immunology, 2002, 168: 3595-3600.
Copyright © 2002 by The American Association of Immunologists

Contribution of Vascular Endothelial Growth Factor to Airway Hyperresponsiveness and Inflammation in a Murine Model of Toluene Diisocyanate-Induced Asthma1

Yong C. Lee3,*, Yong-Geun Kwak{dagger} and Chang H. Song{ddagger}

* Department of Internal Medicine, Research Institute of Clinical Medicine, and Departments of {dagger} Pharmacology and {ddagger} Anatomy, Chonbuk National University Medical School, Chonju, South Korea

Isocyanate chemicals, including toluene diisocyanate (TDI), are currently the most common causes of occupational asthma. Although considerable controversy remains regarding its pathogenesis, TDI-induced asthma is characterized by hyperresponsiveness and inflammation of the airways. One of the histological hallmarks of inflammation is angiogenesis, but the possible role of vascular endothelial growth factor (VEGF), a potent angiogenic cytokine, in TDI-induced asthma is unknown. We developed a murine model to investigate TDI-induced asthma by performing two courses of sensitization with 3% TDI and one challenge with 1% TDI using ultrasonic nebulization to examine the potential involvement of VEGF in that disease. These mice develop the following typical pathophysiological features: airway hyperresponsiveness, airway inflammation, and increased VEGF levels in the airway. Administration of VEGFR inhibitors reduced all these pathophysiological symptoms. These results suggest that VEGF is one of the major determinants of TDI-induced asthma and that the inhibition of VEGF may be a good therapeutic strategy.




This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
D. C. M. Simoes, T. Vassilakopoulos, D. Toumpanakis, K. Petrochilou, C. Roussos, and A. Papapetropoulos
Angiopoietin-1 Protects against Airway Inflammation and Hyperreactivity in Asthma
Am. J. Respir. Crit. Care Med., June 15, 2008; 177(12): 1314 - 1321.
[Abstract] [Full Text] [PDF]

Home page
 Therapeutic Advances in Respiratory DiseaseHome page
A.H. Nissim Ben Efraim and F. Levi-Schaffer
Review: Tissue remodeling and angiogenesis in asthma: the role of the eosinophil
Therapeutic Advances in Respiratory Disease, June 1, 2008; 2(3): 163 - 171.
[Abstract] [PDF]

Home page
 Eur Respir JHome page
K. S. Lee, S. J. Park, S. R. Kim, K. H. Min, K. Y. Lee, Y. H. Choe, S. H. Hong, Y. R. Lee, J. S. Kim, S. J. Hong, et al.
Inhibition of VEGF blocks TGF-{beta}1 production through a PI3K/Akt signalling pathway
Eur. Respir. J., March 1, 2008; 31(3): 523 - 531.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. R. Kim, K. S. Lee, S. J. Park, K. H. Min, K. Y. Lee, Y. H. Choe, Y. R. Lee, J. S. Kim, S. J. Hong, and Y. C. Lee
PTEN Down-Regulates IL-17 Expression in a Murine Model of Toluene Diisocyanate-Induced Airway Disease
J. Immunol., November 15, 2007; 179(10): 6820 - 6829.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
H. Huang, A. Lavoie-Lamoureux, K. Moran, and J.-P. Lavoie
IL-4 stimulates the expression of CXCL-8, E-selectin, VEGF, and inducible nitric oxide synthase mRNA by equine pulmonary artery endothelial cells
Am J Physiol Lung Cell Mol Physiol, May 1, 2007; 292(5): L1147 - L1154.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
A. J Knox, K. Deacon, and R. Clifford
Blanching the airways: steroid effects in asthma
Thorax, April 1, 2007; 62(4): 283 - 285.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
E. D. Fixman, A. Stewart, and J. G. Martin
Basic mechanisms of development of airway structural changes in asthma
Eur. Respir. J., February 1, 2007; 29(2): 379 - 389.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. S. Lee, S. J. Park, S. R. Kim, K. H. Min, S. M. Jin, H. K. Lee, and Y. C. Lee
Modulation of Airway Remodeling and Airway Inflammation by Peroxisome Proliferator-Activated Receptor {gamma} in a Murine Model of Toluene Diisocyanate-Induced Asthma
J. Immunol., October 15, 2006; 177(8): 5248 - 5257.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
K. S. Lee, S. R. Kim, S. J. Park, H. S. Park, K. H. Min, M. H. Lee, S. M. Jin, G. Y. Jin, W. H. Yoo, and Y. C. Lee
Hydrogen Peroxide Induces Vascular Permeability via Regulation of Vascular Endothelial Growth Factor
Am. J. Respir. Cell Mol. Biol., August 1, 2006; 35(2): 190 - 197.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
K. S. Lee, K. H. Min, S. R. Kim, S. J. Park, H. S. Park, G. Y. Jin, and Y. C. Lee
Vascular Endothelial Growth Factor Modulates Matrix Metalloproteinase-9 Expression in Asthma
Am. J. Respir. Crit. Care Med., July 15, 2006; 174(2): 161 - 170.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
D. S. Postma and W. Timens
Remodeling in asthma and chronic obstructive pulmonary disease.
Proceedings of the ATS, July 1, 2006; 3(5): 434 - 439.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
K. S. Lee, S. R. Kim, S. J. Park, H. K. Lee, H. S. Park, K. H. Min, S. M. Jin, and Y. C. Lee
Phosphatase and Tensin Homolog Deleted on Chromosome 10 (PTEN) Reduces Vascular Endothelial Growth Factor Expression in Allergen-Induced Airway Inflammation
Mol. Pharmacol., June 1, 2006; 69(6): 1829 - 1839.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
N. F. Voelkel, R. W. Vandivier, and R. M. Tuder
Vascular endothelial growth factor in the lung
Am J Physiol Lung Cell Mol Physiol, February 1, 2006; 290(2): L209 - L221.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
D. S. Faffe, L. Flynt, K. Bourgeois, R. A. Panettieri Jr., and S. A. Shore
Interleukin-13 and Interleukin-4 Induce Vascular Endothelial Growth Factor Release from Airway Smooth Muscle Cells: Role of Vascular Endothelial Growth Factor Genotype
Am. J. Respir. Cell Mol. Biol., February 1, 2006; 34(2): 213 - 218.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
K. S. Lee, H. S. Park, S. J. Park, S. R. Kim, K. H. Min, S. M. Jin, K.-H. Park, U.-H. Kim, C. Y. Kim, and Y. C. Lee
A Prodrug of Cysteine, L-2-Oxothiazolidine-4-carboxylic Acid, Regulates Vascular Permeability by Reducing Vascular Endothelial Growth Factor Expression in Asthma
Mol. Pharmacol., November 1, 2005; 68(5): 1281 - 1290.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D. S. Faffe, L. Flynt, M. Mellema, T. R. Whitehead, K. Bourgeois, R. A. Panettieri Jr., E. S. Silverman, and S. A. Shore
Oncostatin M causes VEGF release from human airway smooth muscle: synergy with IL-1{beta}
Am J Physiol Lung Cell Mol Physiol, June 1, 2005; 288(6): L1040 - L1048.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
A J Knox, J Stocks, and A Sutcliffe
Angiogenesis and vascular endothelial growth factor in COPD
Thorax, February 1, 2005; 60(2): 88 - 89.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
N. C. Thomson and R. Chaudhuri
Why Is Eosinophilic Bronchitis not Asthma?
Am. J. Respir. Crit. Care Med., July 1, 2004; 170(1): 4 - 5.
[Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
C. Feistritzer, N. C. Kaneider, D. H. Sturn, B. A. Mosheimer, C. M. Kahler, and C. J. Wiedermann
Expression and Function of the Vascular Endothelial Growth Factor Receptor FLT-1 in Human Eosinophils
Am. J. Respir. Cell Mol. Biol., May 1, 2004; 30(5): 729 - 735.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. S. Kazi, S. Lotfi, E. A. Goncharova, O. Tliba, Y. Amrani, V. P. Krymskaya, and A. L. Lazaar
Vascular endothelial growth factor-induced secretion of fibronectin is ERK dependent
Am J Physiol Lung Cell Mol Physiol, March 1, 2004; 286(3): L539 - L545.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
C. A. Redlich, A. V. Wisnewski, and T. Gordon
Mouse Models of Diisocyanate Asthma
Am. J. Respir. Cell Mol. Biol., October 1, 2002; 27(4): 385 - 390.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.